PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 207 filers reported holding PTC THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,522,359 | -47.2% | 157,178 | -4.2% | 0.06% | -44.0% |
| Q2 2023 | $6,669,880 | -19.0% | 164,000 | -3.6% | 0.12% | -31.4% |
| Q1 2023 | $8,238,869 | +25.1% | 170,084 | -1.5% | 0.17% | +17.4% |
| Q4 2022 | $6,588,257 | -26.3% | 172,603 | -3.1% | 0.14% | -29.8% |
| Q3 2022 | $8,941,000 | +21.3% | 178,098 | -3.2% | 0.20% | +27.3% |
| Q2 2022 | $7,370,000 | +7.0% | 183,976 | -0.3% | 0.16% | +32.0% |
| Q1 2022 | $6,887,000 | -10.3% | 184,581 | -4.2% | 0.12% | -7.6% |
| Q4 2021 | $7,674,000 | +7.0% | 192,681 | -0.0% | 0.13% | 0.0% |
| Q3 2021 | $7,173,000 | +4.9% | 192,764 | +19.1% | 0.13% | +6.5% |
| Q2 2021 | $6,841,000 | +41.9% | 161,834 | +58.9% | 0.12% | +34.8% |
| Q1 2021 | $4,821,000 | -30.1% | 101,820 | -9.9% | 0.09% | -34.3% |
| Q4 2020 | $6,897,000 | +22.3% | 113,015 | -6.3% | 0.14% | +4.5% |
| Q3 2020 | $5,639,000 | -11.8% | 120,626 | -4.3% | 0.13% | -15.2% |
| Q2 2020 | $6,393,000 | +11.6% | 125,989 | -1.9% | 0.16% | -9.2% |
| Q1 2020 | $5,731,000 | -20.1% | 128,464 | -13.9% | 0.17% | +10.8% |
| Q4 2019 | $7,170,000 | +28.9% | 149,288 | -9.2% | 0.16% | +19.8% |
| Q3 2019 | $5,561,000 | -28.2% | 164,418 | -4.5% | 0.13% | -27.6% |
| Q2 2019 | $7,744,000 | +9.1% | 172,088 | -8.7% | 0.18% | +13.1% |
| Q1 2019 | $7,096,000 | +7.3% | 188,523 | -2.2% | 0.16% | -6.4% |
| Q4 2018 | $6,615,000 | -30.1% | 192,758 | -4.2% | 0.17% | -12.8% |
| Q3 2018 | $9,457,000 | +19.3% | 201,207 | -14.4% | 0.20% | +20.2% |
| Q2 2018 | $7,926,000 | +5.6% | 234,982 | -15.3% | 0.16% | +10.9% |
| Q1 2018 | $7,505,000 | +55.4% | 277,362 | -4.2% | 0.15% | +58.1% |
| Q4 2017 | $4,828,000 | -24.3% | 289,432 | -9.2% | 0.09% | -21.2% |
| Q3 2017 | $6,379,000 | +6.5% | 318,812 | -2.5% | 0.12% | +2.6% |
| Q2 2017 | $5,992,000 | +77.7% | 326,922 | -4.6% | 0.12% | +79.7% |
| Q1 2017 | $3,372,000 | -12.1% | 342,672 | -2.5% | 0.06% | -16.9% |
| Q4 2016 | $3,834,000 | -27.7% | 351,422 | -7.1% | 0.08% | -27.4% |
| Q3 2016 | $5,300,000 | +94.8% | 378,309 | -2.4% | 0.11% | +79.7% |
| Q2 2016 | $2,721,000 | +3.0% | 387,639 | -5.5% | 0.06% | +5.4% |
| Q1 2016 | $2,641,000 | -78.6% | 410,112 | +7.9% | 0.06% | -78.3% |
| Q4 2015 | $12,315,000 | +93.2% | 380,092 | +59.2% | 0.26% | +83.0% |
| Q3 2015 | $6,375,000 | – | 238,770 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |